USD
$0.00
(0.00%
)At Close (As of Sep 12, 2025)
$1.81B
Market Cap
-
P/E Ratio
-0.56
EPS
$5.95
52 Week High
$0.46
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $76K |
Total Revenue | $76K |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$184M |
Selling General And Administrative | $56M |
Research And Development | $128M |
Operating Expenses | $184M |
Investment Income Net | - |
Net Interest Income | $20M |
Interest Income | $20M |
Interest Expense | $9K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $5.4M |
Income Before Tax | -$164M |
Income Tax Expense | -$598K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$163M |
Comprehensive Income Net Of Tax | - |
Ebit | -$164M |
Ebitda | -$158M |
Net Income | -$61M |
Field | Value (USD) |
---|---|
Total Assets | $441M |
Total Current Assets | $396M |
Cash And Cash Equivalents At Carrying Value | $99M |
Cash And Short Term Investments | $99M |
Inventory | - |
Current Net Receivables | $2.4M |
Total Non Current Assets | $45M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $259M |
Other Current Assets | $35M |
Other Non Current Assets | - |
Total Liabilities | $39M |
Total Current Liabilities | $36M |
Current Accounts Payable | $3.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.5M |
Total Non Current Liabilities | $3.2M |
Capital Lease Obligations | $3.2M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.2M |
Other Current Liabilities | $30M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$995M |
Treasury Stock | - |
Retained Earnings | -$1.2B |
Common Stock | $29K |
Common Stock Shares Outstanding | $98M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$126M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $5.4M |
Capital Expenditures | $30M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $20M |
Cashflow From Financing | $144M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$163M |
Field | Value (USD) |
---|---|
Gross Profit | $76K |
Total Revenue | $76K |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$184M |
Selling General And Administrative | $56M |
Research And Development | $128M |
Operating Expenses | $184M |
Investment Income Net | - |
Net Interest Income | $20M |
Interest Income | $20M |
Interest Expense | $9K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $5.4M |
Income Before Tax | -$164M |
Income Tax Expense | -$598K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$163M |
Comprehensive Income Net Of Tax | - |
Ebit | -$164M |
Ebitda | -$158M |
Net Income | -$61M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
ProKidney Corporation. The company is headquartered in Winston-Salem, North Carolina.